Back

Gene therapy for PKP2 and BAG3

6 December 2025 (09:40 - 09:50)
Organised by: Logo
Seminar Presentation Part of: Session 9 – Precision/Gene based therapy in dilated and arrhythmogenic cardiomyopathy OTHER Open Access ESC Cardio Genomics 2025 Council on Cardiovascular Genomics

About the speaker

Photo
Professor Eva Van Rooij

Hubrecht Institute, Utrecht (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
Abstract: Zebrafish dspb-/- Mutant as a Model for Non-Dilated Left Ventricular Cardiomyopathy: Exploring Cardiac Dysfunction and Exercise Modulation
Miss S. Munteanu (El Palmar, Murcia, ES)
Presentation thumbnail
Small molecules - promises and disappointments in LMNA
Doctor R. Barriales-Villa (Coruna, A, ES)
Slides

Access the full session

Session thumbnail
Session 9 – Precision/Gene based therapy in dilated and arrhythmogenic cardiomyopathy

The Event

Event poster

ESC Cardio Genomics 2025

6 December 2025 09:40 CET
You may be interested in
thumbnail
Congress Presentation
Gene therapy to avoid development of cardiomyopathy
14 April 2023
thumbnail
Congress Presentation
Phenotypic screening identifies HDAC6 inhibitors as cardioprotective agents in BAG3 cardiac-knockout mouse model of dilated cardiomyopathy
29 June 2021
thumbnail
Congress Presentation
Different prognosis of ARVC patients between DSG2 and PKP2 variant carriers
28 August 2022
thumbnail
Congress Session
Genetics in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources